Treatment of the Neuroleptic Malignant Syndrome in International Therapy Guidelines: a Comparative Analysis

Discussion One-third of the selected guidelines do not report any NMS
therapy recommendations. Most guidelines mentioning the NMS do not provide
therapy recommendations that include all relevant treatment options. The
results show a very high heterogeneity, and the recommendations and
statements are of low-evidence levels. The lack of knowledge about the NMS
and its treatment may delay the onset of therapy, impair the quality of
treatment, and lead to a worse outcome or death. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - December 8, 2019 Category: Psychiatry Authors: Sch önfeldt-Lecuona, Carlos Kuhlwilm, Lilli Cronemeyer, Maximilian Neu, Peter Connemann, Bernhard J. Gahr, Maximilian Sartorius, Alexander M ühlbauer, Viktoria Tags: Review Source Type: research